Which of the following is true regarding the management of peripartum cardiomyopathy?

The management of peripartum cardiomyopathy involves careful consideration of various treatment modalities to ensure the safety of both the mother and the fetus. The statement about the cautious use of diuretics during pregnancy reflects the clinical approach required for this condition.

Diuretics can alleviate symptoms such as edema and pulmonary congestion; however, their use must be balanced against potential complications in pregnancy. Excessive diuresis can lead to intravascular volume depletion, which might compromise placental perfusion and harm fetal well-being. Therefore, while diuretics can be part of the treatment plan, they should be used judiciously, and close monitoring is essential to ensure both maternal and fetal health are maintained.

Other management options, such as beta-blockers or anticoagulants, may also be considered based on the clinical scenario. Additionally, the notion that peripartum cardiomyopathy is often asymptomatic is inaccurate; many women experience significant symptoms, necessitating ongoing monitoring and evaluation of cardiac function. Furthermore, patients do not always present in active labor; peripartum cardiomyopathy can arise any time within the peripartum period, emphasizing the need for proper screening and management throughout pregnancy and the postpartum period.